Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Synta Pharmaceuticals Corp."
Count: 38
Selected: 0
| NCT ID | Title |
|---|
| NCT01798485 | A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC | ||
| NCT01039519 | A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) | ||
| NCT01677455 | An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer | ||
| NCT01348126 | Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer | ||
| NCT01562015 | A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) | ||
| NCT01183364 | A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors | ||
| NCT01031225 | A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT00964873 | A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia | ||
| NCT00858572 | STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders | ||
| NCT00688116 | Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors | ||
| NCT00687934 | Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors | ||
| NCT00088114 | STA-4783 and Paclitaxel for Treatment of Solid Tumors | ||
| NCT00084214 | STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma | ||
| NCT00522834 | Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma | ||
| NCT00642629 | A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes | ||
| NCT01280786 | Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT00808418 | A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer | ||
| NCT00276913 | A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT00827203 | A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors | ||
| NCT00234741 | Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease | ||
| NCT00138840 | Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease | ||
| NCT00088101 | STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors | ||
| NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | ||
| NCT00087997 | A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas | ||
| NCT00088062 | STA-5326 in Crohn's Disease Patients | ||
| NCT02261805 | A Phase I/II Study of Ganetespib in Combination With Doxorubicin | ||
| NCT01551693 | STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma | ||
| NCT02334319 | Ganetespib Window of Opportunity Study in Head and Neck Cancers | ||
| NCT01554969 | Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer | ||
| NCT01273896 | Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer | ||
| NCT01111838 | Clinical and Translational Study of STA-9090 | ||
| NCT02008877 | SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) | ||
| NCT01485835 | A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma | ||
| NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | ||
| NCT01167114 | STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer | ||
| NCT01173523 | Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer | ||
| NCT01665937 | STA-9090 in Patients With Advanced Hepatocellular Cancer | ||
| NCT01200238 | STA-9090(Ganetespib) in Metastatic Ocular Melanoma |
